Summaries of health policy coverage from major news organizations
Knight Ridder/Philadelphia Inquirer Profiles ‘Tragic Challenge’ for AIDS Drug Makers Regarding Drug Pricing
Knight Ridder/Philadelphia Inquirer on Saturday profiled the "tragic challenge" that pharmaceutical companies such as GlaxoSmithKline that manufacture antiretroviral drugs face in providing affordable treatments to HIV-positive people in Africa. Despite the fact that some drug makers have lowered the prices of their drugs in developing nations, AIDS advocates criticized the companies for "put[ting] profits ahead of prolonging lives and easing suffering," according to Knight Ridder/Inquirer. GSK, which last month cut its prices of AIDS drugs for 63 developing nations "[a]mid global pressure and the emergence of lower-priced generics," has said that it cannot stay in business or continue to research other treatments without making a profit (Hopkins, Knight Ridder/Philadelphia Inquirer, 5/17). The complete article is available online.
This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.